Clinical trial
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe…
NCT00171535 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171535 |
|---|---|
| Title | Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension |
| Official title | A Study to Evaluate the Safety and Efficacy of Valsartan/Amlodipine Compared to Lisinopril/Hydrochlorothiazide Given Once Daily for 6 Weeks is Patients With Severe Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan/amlodipine |
| Enrollment | 130 |
| Start date | Oct 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: